Categories: News

10x Genomics to Participate in Upcoming June Investor Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences:

  • William Blair 41st Annual Growth Stock Conference
    Fireside Chat on Wednesday, June 2nd at 2:20 p.m. Eastern Time/11:20 p.m. Pacific Time
  • Goldman Sachs 42nd Annual Global Healthcare Conference
    Fireside Chat on Wednesday, June 9th at 3:50 p.m. Eastern Time/12:50 p.m. Pacific Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2019 based on publications and all of the top 20 global pharmaceutical companies by 2019 research and development spend, and have been cited in over 2,500 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises 1,100 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts
Media:
media@10xgenomics.com

Investors:
investors@10xgenomics.com

Staff

Recent Posts

OSSIO Launches Small OSSIOfiber® Suture Anchors, Expanding Best-in-Class Portfolio of Bio-Integrative, Metal-Free Implants to Improve Soft Tissue Fixation

‘The future of orthopedics’WOBURN, Mass.--(BUSINESS WIRE)--#biointegrative--OSSIO Inc., a fast-growing medical technology company focused on evolving…

2 hours ago

Bennett Blau Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Bennett Blau has joined the firm as…

2 hours ago

Home Run! Adia Med of Winter Park’s AHCA Triumph Brings Insurance-Covered Healing to Patients

Winter Park, Florida--(Newsfile Corp. - June 16, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a…

2 hours ago

Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy

First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025)…

2 hours ago